What OptiPin's sourced rule file says about MK-677 with Retatrutide (ibutamoren with a GLP-1): the combination first, then what each one adds alone, then one bloodwork plan for both. It names markers and red flags, never doses.
This page describes a pair, not you. If you have chest pain, trouble breathing, weakness or numbness on one side, yellowing of your skin or eyes, or shaking, sweating and confusion that could be low blood sugar, get urgent medical care now. Nothing here is a dose, a protocol or a safety verdict.
What the rules say about the combination
1 rule fires only when both compounds are present. Each card is rendered from OptiPin's public, sourced rule file. Its labels show the evidence behind each claim (how we label evidence).
Organ load · each compound affects the same organ or marker; the combination is inferred
MK-677 raises glucose against a glucose-lowering drug Clinical evidence
Flagged by: MK-677, Retatrutide
In a randomized trial in older adults, MK-677 raised fasting glucose and lowered insulin sensitivity. Alongside a drug meant to lower glucose, the two pull in opposite directions.
A glucose regimen set without MK-677 can stop holding once it starts.
Markers to check
Fasting glucose and HbA1c before starting and periodically
Get medical care for
Marked thirst, passing much more urine or blurred vision
Evidence
Moderate for MK-677 raising glucose (randomized trial); the combination is inferred.
Every marker the rules above name, listed once. Take it to your clinician or lab.
Fasting glucose and HbA1c before starting and periodically (MK-677 raises glucose against a glucose-lowering drug)
Add anything else you run in the stack checker, which starts with this pair already filled in.
What each compound is
MK-677 (ibutamoren). An oral ghrelin mimetic studied for raising growth hormone secretion. It is not an approved drug. FDA's compounding safety list cites a trial in hip-fracture patients that was stopped early for a possible heart failure signal. More on MK-677.
Retatrutide. An investigational agonist of the GIP, GLP-1 and glucagon receptors. It is not approved. More on Retatrutide.
Log a cycle in OptiPin and it shows whether the stack converts to estradiol, which compounds are 19-nors or 17α-alkylated, when red cell count tends to climb and when your own production is shut down, each with the marker that reads it. All on-device.
In a randomized trial in older adults, MK-677 raised fasting glucose and lowered insulin sensitivity. Alongside a drug meant to lower glucose, the two pull in opposite directions. A glucose regimen set without MK-677 can stop holding once it starts.
What is worth monitoring on MK-677 and Retatrutide?
Fasting glucose and HbA1c before starting and periodically.
When should someone on MK-677 and Retatrutide get medical care?
Marked thirst, passing much more urine or blurred vision.
OptiPin